Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01-10-2012 | Article

Prospective evaluation of clinical scoring systems in infants with bronchiolitis admitted to the intensive care unit

Authors: S. Rödl, B. Resch, N. Hofer, I. Marschitz, G. Madler, E. Eber, G. Zobel

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2012

Login to get access

Abstract

The objective of this investigation was to compare different scoring systems to assess the severity of illness in infants with bronchiolitis admitted to a tertiary paediatric intensive care unit (PICU). Over an 18-year period (1990–2007), infants with bronchiolitis aged up to 12 months and admitted to the PICU were prospectively scored using the Pediatric Risk of Mortality III (PRISM III) score, the Organ System Failure (OSF) score and the Acute Physiologic Score for Children (APSC) within 24 h. Infants were compared as to whether or not bronchiolitis was associated with respiratory syncytial virus (RSV). There was no difference between 113 RSV-positive and 80 RSV-negative infants regarding gestational age, birth weight, rate of premature delivery or bronchopulmonary dysplasia (BPD). The PRISM III score differed significantly between RSV-positive and RSV-negative cases (3.27 ± 0.39 vs. 1.96 ± 0.44, p = 0.006), as did the OSF score (0.56 ± 0.05 vs. 0.35 ± 0.06, p = 0.049) and the APSC (5.16 ± 0.46 vs. 4.1 ± 0.53, p = 0.048). All scores were significantly higher in the subgroup with mechanical ventilation (p < 0.0001). The mean time of ventilation was significantly higher in the RSV-positive group compared to the RSV-negative group (6.39 ± 1.74 days vs. 2.4 ± 0.47 days, p < 0.001). Infants suffering from RSV-positive bronchiolitis had higher clinical scores corresponding with the severity of bronchiolitis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116PubMedCrossRef Pollack MM, Ruttimann UE, Getson PR (1988) Pediatric risk of mortality (PRISM) score. Crit Care Med 16:1110–1116PubMedCrossRef
2.
go back to reference Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24:743–752PubMedCrossRef Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24:743–752PubMedCrossRef
3.
go back to reference Pollack MM, Patel KM, Ruttimann UE (1997) The Pediatric Risk of Mortality III—Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 131:575–581PubMedCrossRef Pollack MM, Patel KM, Ruttimann UE (1997) The Pediatric Risk of Mortality III—Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 131:575–581PubMedCrossRef
4.
go back to reference Wilkinson JD, Pollack MM, Glass NL, Kanter RK, Katz RW, Steinhart CM (1987) Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 111:324–328PubMedCrossRef Wilkinson JD, Pollack MM, Glass NL, Kanter RK, Katz RW, Steinhart CM (1987) Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 111:324–328PubMedCrossRef
5.
go back to reference Zobel G, Kuttnig M, Grubbauer HM, Rödl S (1990) Evaluation of clinical scoring systems in critically ill infants and children. Clin Intensive Care 1:202–206PubMed Zobel G, Kuttnig M, Grubbauer HM, Rödl S (1990) Evaluation of clinical scoring systems in critically ill infants and children. Clin Intensive Care 1:202–206PubMed
6.
go back to reference Zobel G, Kuttnig M, Ring E, Grubbauer HM (1990) Clinical scoring systems in children with continuous extracorporeal renal support. Child Nephrol Urol 10:14–17PubMed Zobel G, Kuttnig M, Ring E, Grubbauer HM (1990) Clinical scoring systems in children with continuous extracorporeal renal support. Child Nephrol Urol 10:14–17PubMed
7.
go back to reference Zobel G, Rödl S, Rigler B, Metzler H, Dacar D, Grubbauer HM, Beitzke A (1993) Prospective evaluation of clinical scoring systems in infants and children with cardiopulmonary insufficiency after cardiac surgery. J Cardiovasc Surg (Torino) 34:333–337 Zobel G, Rödl S, Rigler B, Metzler H, Dacar D, Grubbauer HM, Beitzke A (1993) Prospective evaluation of clinical scoring systems in infants and children with cardiopulmonary insufficiency after cardiac surgery. J Cardiovasc Surg (Torino) 34:333–337
8.
go back to reference van Keulen JG, Polderman KH, Gemke RJBJ (2005) Reliability of PRISM and PIM scores in paediatric intensive care. Arch Dis Child 90:211–214PubMedCrossRef van Keulen JG, Polderman KH, Gemke RJBJ (2005) Reliability of PRISM and PIM scores in paediatric intensive care. Arch Dis Child 90:211–214PubMedCrossRef
9.
go back to reference van Keulen JG, Gemke RJBJ, Polderman KH (2005) Effect of training and strict guidelines on the reliability of risk adjustment systems in paediatric intensive care. Intensive Care Med 31:1229–1234PubMedCrossRef van Keulen JG, Gemke RJBJ, Polderman KH (2005) Effect of training and strict guidelines on the reliability of risk adjustment systems in paediatric intensive care. Intensive Care Med 31:1229–1234PubMedCrossRef
11.
go back to reference Groothuis JR, Simoes EAF, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, Tristram DA, Siber GR, Prince GA, Van Raden M, Hemming G (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329:1524–1530PubMedCrossRef Groothuis JR, Simoes EAF, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, Tristram DA, Siber GR, Prince GA, Van Raden M, Hemming G (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329:1524–1530PubMedCrossRef
12.
go back to reference Resch B, Gusenleitner W, Müller W (2002) The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years. Infection 30:193–197PubMedCrossRef Resch B, Gusenleitner W, Müller W (2002) The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years. Infection 30:193–197PubMedCrossRef
13.
go back to reference Resch B, Gusenleitner W, Müller W, Haas J (2006) Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29–32 weeks. Eur J Clin Microbiol Infect Dis 25:120–122PubMedCrossRef Resch B, Gusenleitner W, Müller W, Haas J (2006) Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29–32 weeks. Eur J Clin Microbiol Infect Dis 25:120–122PubMedCrossRef
14.
go back to reference Welliver RC (2009) Bronchiolitis and infectious asthma. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (eds) Feigin and Cherry’s textbook of pediatric infectious diseases, 6th edn. Saunders Elsevier, Philadelphia, pp 277–287 Welliver RC (2009) Bronchiolitis and infectious asthma. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (eds) Feigin and Cherry’s textbook of pediatric infectious diseases, 6th edn. Saunders Elsevier, Philadelphia, pp 277–287
15.
go back to reference Resch B, Gusenleitner W, Mueller WD (2007) Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection. Acta Paediatr 96:495–498PubMedCrossRef Resch B, Gusenleitner W, Mueller WD (2007) Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection. Acta Paediatr 96:495–498PubMedCrossRef
16.
go back to reference Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, Lacroix J, Leclerc F (2003) Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 362:192–197PubMedCrossRef Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, Lacroix J, Leclerc F (2003) Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 362:192–197PubMedCrossRef
17.
go back to reference Slater A, Shann F, Pearson G, Paediatric Index of Mortality (PIM) Study Group (2003) PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 29:278–285PubMed Slater A, Shann F, Pearson G, Paediatric Index of Mortality (PIM) Study Group (2003) PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 29:278–285PubMed
18.
go back to reference Midulla F, Scagnolari C, Bonci E, Pierangeli A, Antonelli G, De Angelis D, Berardi R, Moretti C (2010) Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 95:35–41PubMedCrossRef Midulla F, Scagnolari C, Bonci E, Pierangeli A, Antonelli G, De Angelis D, Berardi R, Moretti C (2010) Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 95:35–41PubMedCrossRef
19.
go back to reference Tasker RC, Roe MFE, Bloxham DM, White DK, Ross-Russell RI, O’Donnell DR (2004) The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy. Intensive Care Med 30:2257–2262PubMedCrossRef Tasker RC, Roe MFE, Bloxham DM, White DK, Ross-Russell RI, O’Donnell DR (2004) The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy. Intensive Care Med 30:2257–2262PubMedCrossRef
20.
go back to reference Roe MFE, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O’Donnell DR (2004) Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 137:139–145PubMedCrossRef Roe MFE, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O’Donnell DR (2004) Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol 137:139–145PubMedCrossRef
21.
go back to reference Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, Castro M (2005) Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115:e7–e14PubMed Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, Castro M (2005) Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 115:e7–e14PubMed
23.
go back to reference Resch B, Gusenleitner W, Mandl C, Müller W (2000) Epidemiology of respiratory syncytial virus infection in Southern Austria. Pediatr Infect Dis J 19:587–588PubMed Resch B, Gusenleitner W, Mandl C, Müller W (2000) Epidemiology of respiratory syncytial virus infection in Southern Austria. Pediatr Infect Dis J 19:587–588PubMed
24.
go back to reference Thorburn K (2009) Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 94:99–103PubMedCrossRef Thorburn K (2009) Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 94:99–103PubMedCrossRef
Metadata
Title
Prospective evaluation of clinical scoring systems in infants with bronchiolitis admitted to the intensive care unit
Authors
S. Rödl
B. Resch
N. Hofer
I. Marschitz
G. Madler
E. Eber
G. Zobel
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1612-z

Other articles of this Issue 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine